'Back to science' theme for Wellington's second life sciences conference

'Back to science' theme for Wellington's second life sciences conference
Ian Wisenberg (left), Melissa Yiannoutsos, David Allen, Sonya Williams, Kate de Ridder and moderator Stuart Roberts talk biotech investment. (Image: BusinessDesk)
Greg Hurrell
With reform to genetic engineering laws in the pipeline, New Zealand’s biotech sector put politics to one side at the second life sciences conference in Wellington this week.This year, the science took centre stage. The keynote speaker was Jon Pilcher, of Neuren Pharmaceuticals, who launched straight into a talk on improved synthetic peptides to treat neurodevelopmental disorders. That probably indicated a desire to get down to the sector’s core business after last year.In 2023, speaker after speaker took the rostrum to voice their...

More Technology

Sharesies founders sell down
Markets

Sharesies founders sell down

Global tech investor Rahul Mehta appears on the register for the first time.

A blueprint to beat our economic malaise
Opinion

Peter Griffin: A blueprint to beat our economic malaise

NZ must trade talk for execution and invest in talent to escape its economic woes. 

Kordia sells its managed IT services business
News in Brief

Kordia sells its managed IT services business

Kordia’s 2025 annual report put its headcount at 456.

Staff reporters 04 Nov 2025
Being AI’s bold plan: No business, still listed
Markets

Being AI’s bold plan: No business, still listed

From wannabe Google challenger to now selling off its last business to escape debt.